Pancreatic cancer early detection: Expanding higher-risk group with clinical and metabolomics parameters

Table 2 Results of screening programs for pancreatic cancer in high-risk groups n (%)

Study	CAPS1	CAPS2	CAPS3	U of Washington	FaPaCa	Dutch Study
Diagnostic yield	2 (5.3)	8 (10)	92 (43)	10 (13)	1 (1.3)	10 (23)

Positive finding of abnormal imaging such as mass (solid, cyst) or abnormal duct in the cases. CAPS: Cancer of the Pancreas Screening Study; FaPaCa: Familial Pancreatic Cancer Study.